Pediatric Infection and Vaccine

  • 제27권2호
  • /
  • Pages.102-110
  • /
  • 2020
  • /
  • 2384-1079(pISSN)
  • /
  • 2384-1087(eISSN)
대한소아감염학회 (The Korean Society of Pediatric Infectious Diseases)
권호 표지
DOI QR코드

DOI QR Code

Human Parechovirus: an Emerging Cause of Sepsis-Like Syndrome in Infants Aged under 3 Months

  • Roh, Da Eun (Department of Pediatrics, School of Medicine, Kyungpook National University, Kyungpook National University Children's Hospital) ;
  • Kwon, Jung Eun (Department of Pediatrics, School of Medicine, Kyungpook National University, Kyungpook National University Children's Hospital) ;
  • Kim, Yeo Hyang (Department of Pediatrics, School of Medicine, Kyungpook National University, Kyungpook National University Children's Hospital)
  • 투고 : 2019.12.04
  • 심사 : 2020.05.17
  • 발행 : 2020.08.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 이번연구의목적은 human parechovirus (HPeV)로유발된패혈증의증을보였던 3개월미만의영아를대상으로임상적 특징 및 경과를 조사하는 것이다. 방법: 2018년 7월 1일부터 8월 31일까지 패혈증 의증으로 입원한 3개월 미만 영아들의 의무기록을 확인하였다. 환자들은 뇌척수액을 이용하여 역전사 중합효소 연쇄반응 검사를 시행하고 결과에 따라 HPeV 감염군(1군, 11명), 장바이러스 감염군(2군, 13명), 바이러스가 검출되지 않은 군(3군, 15명)으로 구분하였다. 결과: 1군은 빈맥, 빈호흡, 무호흡, 저혈압, 피부 변화를 보이는 환자가 2, 3군 보다 많았다(P<0.05). 또한 1군은 혈중 총 백혈구수가 다른 군에 비해 낮았다(5,622±2,355/μL, 9,397±2,282/μL and 12,312±7,452/μL, P=0.005). 뇌척수액 백혈구 수도 1군은 2, 3군에 비하여 낮았다 (0.9±1.7/μL, 85.1±163.6/μL, and 3.7±6.9/μL, P=0.06). 치료에서도 1군은 2, 3군 보다 승압제 보조(36.6% vs. 0% and 6.6%), 기계 환기 적용(18.1% vs. 0% and 0%)과 고유량 산소 사용(45.4% vs. 15.3% and 6.6%)이 더 많았다. 모든 환자들은 합병증 없이 회복 되었다. 결론: HPeV 감염은 심각한 임상 경과를 보이고, 3개월 미만의 영아에서 패혈증 유사 증후군의 원인이 될 수 있다. 따라서, HPeV 감염 여부를 조기에 진단하고 적절한 치료를 시작하는 것이 필요하다.

Purpose: This study aimed to investigate the clinical characteristics of human parechovirus (HPeV) infection in sepsis-like syndrome in infants aged under 3 months. Methods: Medical records of infants aged under 3 months with sepsis-like symptoms who were admitted between July 1, 2018 and August 31, 2018 were reviewed. A multiplex reverse transcription-polymerase chain reaction panel test was performed on the cerebrospinal fluid (CSF). Thirty-nine enrolled infants were categorized into three groups: 11 in group 1 (HPeV detected in the CSF), 13 in group 2 (enterovirus detected in the CSF), and 15 in group 3 (no virus detected in the CSF). Results: Compared with groups 2 and 3, a higher proportion of group 1 had tachycardia, tachypnea, apnea, and hypotension (P<0.05). A significantly lower white blood cell (WBC) count was noted in group 1 than in groups 2 and 3 (5,622±2,355/μL, 9,397±2,282/μL, and 12,312±7,452/μL, respectively; P=0.005). The CSF WBC count was lower in group 1 than in groups 2 and 3 (0.9±1.7/μL, 85.1±163.6/μL, and 3.7±6.9/μL, respectively; P=0.068). The proportion of patients requiring inotrope support (36.6% vs. 0% and 6.6%), mechanical ventilation (18.1% vs. 0% and 0%), and high flow nasal cannula (45.4% vs. 15.3% and 6.6%) was higher in group 1 than in groups 2 and 3. All patients recovered completely without complications. Conclusions: HPeV infection shows a severe clinical course and can cause a severe sepsis-like syndrome in infants aged under 3 months. Early diagnosis and proper treatment of HPeV infection are required.

키워드

참고문헌

  1. Olijve L, Jennings L, Walls T. Human parechovirus: an increasingly recognized cause of sepsis-like illness in young infants. Clin Microbiol Rev 2017;31:e00047-17.
  2. Aizawa Y, Izumita R, Saitoh A. Human parechovirus type 3 infection: an emerging infection in neonates and young infants. J Infect Chemother 2017;23:419-26. https://doi.org/10.1016/j.jiac.2017.04.009
  3. Khatami A, McMullan BJ, Webber M, Stewart P, Francis S, Timmers KJ, et al. Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia. Clin Infect Dis 2015;60:228-36. https://doi.org/10.1093/cid/ciu784
  4. Cumming G, Khatami A, McMullan BJ, Musto J, Leung K, Nguyen O, et al. Parechovirus genotype 3 outbreak among infants, New South Wales, Australia, 2013-2014. Emerg Infect Dis 2015;21:1144-52. https://doi.org/10.3201/eid2107.141149
  5. Han TH, Chung JY, You SJ, Youn JL, Shim GH. Human parechovirus-3 infection in children, South Korea. J Clin Virol 2013;58:194-9. https://doi.org/10.1016/j.jcv.2013.05.023
  6. Seo JH, Yeom JS, Youn HS, Han TH, Chung JY. Prevalence of human parechovirus and enterovirus in cerebrospinal fluid samples in children in Jinju, Korea. Korean J Pediatr 2015;58:102-7. https://doi.org/10.3345/kjp.2015.58.3.102
  7. Fleming S, Thompson M, Stevens R, Heneghan C, Pluddemann A, Maconochie I, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet 2011;377:1011-8. https://doi.org/10.1016/S0140-6736(10)62226-X
  8. Task Force on Blood Pressure Control in Children. Report of the second task force on blood pressure control in children--1987. Pediatrics 1987;79:1-25.
  9. Task Force on Prolonged Infantile Apnea. Prolonged infantile apnea: 1985. Pediatrics 1985;76:129-31.
  10. Byington CL, Kendrick J, Sheng X. Normative cerebrospinal fluid profiles in febrile infants. J Pediatr 2011;158:130-4. https://doi.org/10.1016/j.jpeds.2010.07.022
  11. Harvala H, Simmonds P. Human parechoviruses: biology, epidemiology and clinical significance. J Clin Virol 2009;45:1-9. https://doi.org/10.1016/j.jcv.2009.03.009
  12. Britton PN, Jones CA, Macartney K, Cheng AC. Parechovirus: an important emerging infection in young infants. Med J Aust 2018;208:365-9. https://doi.org/10.5694/mja18.00149
  13. Renaud C, Harrison CJ. Human parechovirus 3: the most common viral cause of meningoencephalitis in young infants. Infect Dis Clin North Am 2015;29:415-28. https://doi.org/10.1016/j.idc.2015.05.005
  14. Jeziorski E, Schuffenecker I, Bohrer S, Pain JB, Segondy M, Foulongne V. Relevance of human parechovirus detection in cerebrospinal fluid samples from young infants with sepsis-like illness. J Clin Lab Anal 2015;29:112-5. https://doi.org/10.1002/jcla.21737
  15. Sharp J, Harrison CJ, Puckett K, Selvaraju SB, Penaranda S, Nix WA, et al. Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations. Pediatr Infect Dis J 2013;32:213-6. https://doi.org/10.1097/INF.0b013e318276b328
  16. Ferreras Antolin L, Kadambari S, Braccio S, Tang JW, Xerry J, Allen DJ, et al. Increased detection of human parechovirus infection in infants in England during 2016: epidemiology and clinical characteristics. Arch Dis Child 2018;103:1061-6. https://doi.org/10.1136/archdischild-2017-314281
  17. Loi C, Magnano M, Ravaioli GM, Neri I. An erythematous palmoplantar rash due to human parechovirus. Arch Dis Child 2016;101:1070. https://doi.org/10.1136/archdischild-2016-311044
  18. Shoji K, Komuro H, Miyata I, Miyairi I, Saitoh A. Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants. Pediatr Infect Dis J 2013;32:233-6. https://doi.org/10.1097/INF.0b013e31827b1fd0
  19. Schuffenecker I, Javouhey E, Gillet Y, Kugener B, Billaud G, Floret D, et al. Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases. J Clin Virol 2012;54:337-41. https://doi.org/10.1016/j.jcv.2012.04.016
  20. Harvala H, Griffiths M, Solomon T, Simmonds P. Distinct systemic and central nervous system disease patterns in enterovirus and parechovirus infected children. J Infect 2014;69:69-74. https://doi.org/10.1016/j.jinf.2014.02.017
  21. Verboon-Maciolek MA, Krediet TG, Gerards LJ, de Vries LS, Groenendaal F, van Loon AM. Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr Infect Dis J 2008;27:241-5. https://doi.org/10.1097/INF.0b013e31815c1b07
  22. Britton PN, Dale RC, Nissen MD, Crawford N, Elliott E, Macartney K, et al. Parechovirus encephalitis and neurodevelopmental outcomes. Pediatrics 2016;137:e20152848. https://doi.org/10.1542/peds.2015-2848
  23. Shakeel S, Westerhuis BM, Domanska A, Koning RI, Matadeen R, Koster AJ, et al. Multiple capsid-stabilizing interactions revealed in a high-resolution structure of an emerging picornavirus causing neonatal sepsis. Nat Commun 2016;7:11387. https://doi.org/10.1038/ncomms11387
  24. Wildenbeest JG, Wolthers KC, Straver B, Pajkrt D. Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant. Pediatrics 2013;132:e243-7. https://doi.org/10.1542/peds.2012-1136